Furthermore, a study found elevated expression of lymphocyte activation gene 3 (LAG-3), CTLA-4, and TIM-3 on PD-1+CD8+ T cells in patients with HBV-associated HCC compared with CHB [59]. Here, LAG3 is linked to hepatocellular carcinoma.